Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Carefully remove the central part of the metal cap from the vial and disinfect the upper surface with an alcohol swab
Each vial carries a unique batch identifier you can cross-reference against the public COA on our Lab Results page
Compound Receptors Peak trial weight loss Lean mass as share of loss Semaglutide (Ozempic/Wegovy) GLP-1 ~14.9% (STEP-1, 68 wk) ~39% Tirzepatide (Mounjaro/Zepbound) GLP-1 + GIP ~20.9% (SURMOUNT-1, 72 wk) ~25-40% Retatrutide GLP-1 + GIP + GCGR ~24.2% (Phase 2, 48 wk) Comparable class range Best for understanding the takeaway: the percentage of loss that is lean mass is roughly constant across the class
Our dermatologists may recommend maintenance sessions if necessary
A Food and Drug Administration advisory committee narrowly voted in favor of loosening restrictions on peptides over strong objections from agency career scientists
US$ 26.38
US$ 24.62
US$ 22.11
US$ 24.50
